passages.id: split_1_test_2282_passage
passages.type: progene_text
passages.text: In Japan , oprelvekin is being developed by Genetics Institute and Yamanouchi ; phase III trials have commenced [ 295049 ] and were ongoing in May 2001 [ 411763 ] .